RHOC and breast cancer: Cdc42 is inhibited by StarD13 but it remains active at sites of invadopodia, where Cdc42 is required for activating nucleation promoting factors in a similar way to the spatial regulation described for RhoA and RhoC in breast cancer cells [61] (Fig. 7, model).